Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis

Project: Research

Project Details

StatusActive
Effective start/end date01/17/20 → 12/31/26

Funding

  • Pharmaceutical Research Associates Incorporated: $118,646.20